Benzinga | Aug 10, 2021 04:08PM EDT

Biodesix Q2 EPS $(0.41) Misses $(0.29) Estimate, Sales $11.88M Up From $4.24M YoY

Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.29) by 41.38 percent. The company reported $11.88 million in sales this quarter. This is a 180.37 percent increase over sales of $4.24 million the same period last year.